🚀Presidential #ESMO26
HARMONi-GI1 in advanced BTC

🟢Ivonescimab-GemCis vs Durva-Gemcis

✅mOS: 14.9 vs. 12.1 months; HR 0.75, 95% CI 0.61-0.92, P = 0.0031
✅mPFS: 8.4 vs. 5.8 months, HR 0.61, 95% CI 0.51-0.72, P <0.0001
✅ORR: 53.8 % vs. 32.5 % (P <0.0001)

#cancer #oncology #MedX @OncoAlert #biliary #cholangiocarcinoma #gallbladder